Article info
PDFHow to understand it
RT-QuIC: a new test for sporadic CJD
- Correspondence to Dr Alison J E Green, Centre for Clinical Brain Sciences, The National CJD Research & Surveillance Unit, University of Edinburgh, Edinburgh EH4 2XU, UK; alison.green{at}ed.ac.uk
Citation
RT-QuIC: a new test for sporadic CJD
Publication history
- Accepted August 27, 2018
- First published October 3, 2018.
Online issue publication
January 17, 2019
Article Versions
- Previous version (3 October 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0
Other content recommended for you
- CJD mimics and chameleons
- Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene
- Characteristics of Chinese patients with genetic CJD who have E196A or E196K mutation in PRNP: comparative analysis of patients identified in the Chinese National CJD Surveillance System
- Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy
- MM2-type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type
- Imaging and CSF analyses effectively distinguish CJD from its mimics
- Intensity of human prion disease surveillance predicts observed disease incidence
- Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease
- Molecular pathology of neurodegenerative diseases: principles and practice
- Study protocol for enhanced CJD surveillance in the 65+ years population group in Scotland: an observational neuropathological screening study of banked brain tissue donations for evidence of prion disease